Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Most ovarian cancers start in the fallopian tubes, study finds

Most ovarian cancers start in the fallopian tubes, study finds

Higher level of tumor-infiltrating lymphocytes linked to better survival for ovarian cancer patients

Higher level of tumor-infiltrating lymphocytes linked to better survival for ovarian cancer patients

New generation of drugs targets cancer cells’ vulnerability with broken genes

New generation of drugs targets cancer cells’ vulnerability with broken genes

Research finds higher rates of cancer in world's ‘better’ countries

Research finds higher rates of cancer in world's ‘better’ countries

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

MIT engineers design more effective synthetic mRNA delivery system

MIT engineers design more effective synthetic mRNA delivery system

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Prostate cancer screening reduces cancer deaths finds new analysis

Prostate cancer screening reduces cancer deaths finds new analysis

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Coffee consumption connected to a longer life

Coffee consumption connected to a longer life

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

New clinical trial to test cancer drug in patients with advanced solid tumors

New clinical trial to test cancer drug in patients with advanced solid tumors

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes